George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGINV.L Regulatory News (GINV)

  • There is currently no data for GINV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to Full Year Results Queries from SGX-ST

14 Mar 2023 09:30

RNS Number : 8925S
Global Invacom Group Limited
14 March 2023
 

 

 

 

GLOBAL INVACOM GROUP LIMITED

(Incorporated in the Republic of Singapore)

(Company Registration No. 200202428H)

 

 

RESPONSE TO QUERIES FROM SINGAPORE EXCHANGE SECURITIES TRADING LIMITED ("SGX-ST") ON THE FULL YEAR RESULTS FOR FY2022

 

 

The Board of Directors (the "Board") of GLOBAL INVACOM GROUP LIMITED (the "Company") refers to the following queries raised by the SGX-ST on 10 March 2023 and would like to provide additional information in relation to the Company's full year results for the financial year ended 31 December 2022 ("FY2022"), as follows:

SGX-ST's Query 1:

 

Please disclose:

 

(i) the nature of the non-current receivables; and

 

Company's response to Query 1(i):

The non-current receivables of US$54,000 are deposits for electricity and water for the Group's subsidiary in the United States.

(ii) the Board's assessment of the recoverability of the non-current other receivables and prepayments.

Company's response to Query 1(ii):

 

The Board is of the opinion that the non-current other receivables and prepayments are recoverable.

SGX-ST's Query 2:

 

It is disclosed on page 17 of the unaudited financial statements that the impairment charge in 2H FY2022 and FY2022 was attributed to a goodwill impairment of US$5.2 million, which is non-cash in nature, related to the performance of the Group's US subsidiary. The requirement to recognise this charge has arisen due to the sustained loss making position of the Group's US subsidiary. In this regard, please disclose the following information:

 

(i) how the amount of impairment was determined;

 

(ii) whether any valuation was conducted; the value placed on the relevant assets; the basis and the date of such valuation;

 

 

Company's response to Queries 2(i) & 2(ii):

 

The Group has goodwill of US$5.2 million allocated to the United States subsidiary cash-generating units ("CGUs") as at 31 December 2022.

 

These CGUs are tested for impairment annually. Management applies the value in use method to determine the recoverable amount of each CGU. Any shortfall of the recoverable amounts against the carrying amounts are recognised as an impairment loss. The recoverable amount is determined based on estimates of forecasted revenue, growth rates, profit margins and discount rates.

 

(iii) the Board's confirmation as to whether it is satisfied with the reasonableness of the methodologies used to determine amount of impairment.

Company's response to Query 2(iii):

The Board is satisfied with the reasonableness of the methodologies used to determine the amount of impairment.

 

 

SGX-ST's Query 3:

 

Please explain why no interest income was recorded during the financial period ended 31 December 2022 when the Company has significant cash and bank balance amounting to US$9,244,000.

Company's response to Query 3:

 

The majority of the Group's cash and cash balances are in the United Kingdom bearing either zero or very low interest, resulting in interest income of less than US$100 which is below the reporting threshold.

 

 

SGX-ST's Query 4:

 

Please provide information on the Group's inventory turnover days. Company's response to Query 4:

 

The Group's inventory turnover days are as follows:

 

 

FY2022

FY2021

Inventory turnover days

150 days

145 days

 

 

SGX-ST's Query 5:

 

Please disclose a breakdown of other payables amounting to US$3,109,000 and US$4,447,000 as at 31 December 2022 and 31 December 2021 respectively. For other payables, please disclose the nature of these other payables and whether the counterparties are related parties.

 

 

Company's response to Query 5:

 

The nature of other payables are as follows:

 

 

FY2022

FY2021

 

US$'000

US$'000

Accrued operating expenses

1,574

2,409

Provision for warranty

148

235

Customers advances received

781

1,085

GST/VAT payables

84

177

Other creditors

522

693

3,109

4,599

 

No counterparties are related parties.

 

 

SGX-ST's Query 6:

 

Please confirm if there are any outstanding convertibles and if yes, the number shares that may be issued on conversion of the outstanding convertibles.

 

Company's response to Query 6:

 

There are no outstanding convertibles.

BY ORDER OF THE BOARD

 

 

Gordon Blaikie

Interim Chief Executive Officer

 

 

14 March 2023

 

 

For further information, please contact:

 

Global Invacom Group Limited

www.globalinvacom.com

Gordon Blaikie, Interim Chief Executive Officer

via Vigo Consulting

 

Strand Hanson Limited (Nominated Adviser and Broker)

www.strandhanson.co.uk

James Harris / Richard Johnson / David Asquith

Tel: +44 20 7409 3494

 

Vigo Consulting (UK Media & Investor Relations)

www.vigoconsulting.com

Jeremy Garcia / Fiona Hetherington / Kendall Hill

Tel: +44 20 7390 0238

ginv@vigoconsulting.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANDLFEADEEA
Date   Source Headline
3rd Nov 20237:05 amRNSCancellation - Global Invacom Group Ltd
26th Oct 202311:03 amRNSResult of EGM
26th Sep 20237:30 amRNSNotice of EGM
6th Sep 20237:30 amRNSGlobal Skyware announces contract with Eutelsat
6th Sep 20237:00 amRNSProposed Cancellation to Trading on AIM
18th Aug 20237:30 amRNSAppointment of Joint Company Secretary
11th Aug 20237:30 amRNSHalf-year Report
3rd Aug 20237:30 amRNSTrading Update
12th May 202310:30 amRNSMinutes of AGM
26th Apr 202310:33 amRNSResults of Annual General Meeting
11th Apr 20237:00 amRNSNotice of AGM & Audited Financial Statements
3rd Apr 20237:00 amRNSChange of Registered Office
14th Mar 20239:30 amRNSResponse to Full Year Results Queries from SGX-ST
2nd Mar 20239:30 amRNSGrant of Options
27th Feb 20237:00 amRNSFinal Results
15th Feb 20231:20 pmRNSTrading Update
9th Dec 20229:20 amRNSBoard changes
24th Nov 20229:20 amRNSTrading Update
22nd Aug 202210:30 amRNSGrant of Options
12th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20227:00 amRNSTrading Update
15th Jul 202210:30 amRNSDissolution of Wholly-Owned Subsidiary
31st May 202210:30 amRNSGlobal Foxcom Releases New Mini-GNSS Repeater Kit
27th Apr 202211:00 amRNSResults of AGM
25th Apr 20227:02 amRNSResponse to Annual Report Queries from SIAS
25th Apr 20227:01 amRNSResponse to Annual Report Queries from SGX-ST
25th Apr 20227:00 amRNSResponse to Shareholder AGM Questions
12th Apr 20227:00 amRNSPosting of Annual Report and Notice of AGM
25th Feb 20227:00 amRNSFinal Results
21st Dec 20217:00 amRNSAlign Research Publishes Research Note
22nd Oct 20217:00 amRNSAward of funding for development of user terminal
13th Aug 20217:00 amRNSResults for the six months ended 30 June 2021
4th Aug 20217:00 amRNSTrading Update
13th Jul 202110:30 amRNSDeath of UK Financial Controller
1st Jul 20217:00 amRNSDirector and Management Changes
28th Apr 202110:30 amRNSResult of AGM
27th Apr 202111:00 amRNSResponse to Annual Report Queries from SGX-ST
27th Apr 202110:20 amRNSResponse to Shareholder AGM Questions
13th Apr 20217:00 amRNSPosting of Annual Report and Notice of AGM
12th Mar 20217:00 amRNSResponse to Queries from SGX-ST
1st Mar 20217:00 amRNSFinal Results
18th Dec 20207:00 amRNSDirectorate Change
9th Oct 20203:15 pmRNSDirectorate Change
24th Sep 20207:00 amRNSApplication for Time Extension to Appoint Director
14th Aug 202010:37 amRNSIncorporation of Indirect Wholly Owned Subsidiary
13th Aug 20207:00 amRNSResults for the six months ended 30 June 2020
3rd Jul 20207:00 amRNSAppointment of Nominated Adviser and Broker
25th Jun 202010:22 amRNSResult of AGM
3rd Jun 20207:01 amRNSDirectorate Change
3rd Jun 20207:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.